Literature DB >> 9915336

Psychotropic drugs used in anesthesia practice: abuse liability and epidemiology of abuse.

J P Zacny1, J L Galinkin.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 9915336     DOI： 10.1097/00000542-199901000-00033

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  6 in total

1.  Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil.

Authors:  Aida Mohammadkhani; Jennifer E Fragale; Caroline B Pantazis; Hannah E Bowrey; Morgan H James; Gary Aston-Jones
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

2.  Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice.

Authors:  Lisa J Merlo; William M Greene; Raymond Pomm
Journal:  J Addict Med       Date:  2011-12       Impact factor: 3.702

3.  Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.

Authors:  Li-Tzy Wu; William E Schlenger; Deborah M Galvin
Journal:  Drug Alcohol Depend       Date:  2006-02-17       Impact factor: 4.492

4.  Reasons for misuse of prescription medication among physicians undergoing monitoring by a physician health program.

Authors:  Lisa J Merlo; Supachoke Singhakant; Simone M Cummings; Linda B Cottler
Journal:  J Addict Med       Date:  2013 Sep-Oct       Impact factor: 3.702

5.  Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil.

Authors:  Aida Mohammadkhani; Morgan H James; Caroline B Pantazis; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-09-14       Impact factor: 3.252

6.  Obstructive nephropathy and kidney injury associated with ketamine abuse.

Authors:  Nicholas M Selby; John Anderson; Peter Bungay; Lindsay J Chesterton; Nitin V Kolhe
Journal:  NDT Plus       Date:  2008-05-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.